DNMT3B and acute myeloid leukemia: However, the expression of TET2 was significantly downregulated relative to AML due to promoter hypermethylation, whereas DNMT1, DNMT3A, and DNMT3B were slightly upregulated by either demethylation or gained chromatin interactions.